News

Hungary curbs drug company advertising

BMJ 2001; 322 doi: http://dx.doi.org/10.1136/bmj.322.7292.947/a (Published 21 April 2001) Cite this as: BMJ 2001;322:947
  1. Carl Kovac
  1. Budapest

    Hungary's pharmaceutical manufacturers are facing a clampdown on the methods they use to advertise and market their products to doctors. A health ministry decree, due to become effective within the next few weeks, will drastically limit what has been termed “rampant marketing” by manufacturers. “The era of uncontrolled drug advertising, unsupervised vaccine programmes, leaflets promoting pharmacies, and medications jamming mailboxes is over,” said health minister István Mikola.

    The new decree is seen by the health ministry as essential to bringing down the …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe